Yee V C, Le Trong I, Bishop P D, Pedersen L C, Stenkamp R E, Teller D C
Biochemistry Department, University of Washington, Seattle 98195-7350, USA.
Semin Thromb Hemost. 1996;22(5):377-84. doi: 10.1055/s-2007-999035.
The three-dimensional structures of several forms of the factor XIII A subunit have been determined using single crystal x-ray diffraction methods. Our crystallographic studies have provided the first detailed structural view of the factor XIII A subunit and information that is useful for understanding transglutaminase function. We have identified a conserved Cys314-His373-Asp396 catalytic triad of residues in the active site of the molecule and a number of other conserved residues that may play important roles as well. The calcium and strontium structures have revealed several conserved acidic residues (Asp438, Glu485, and Glu490) involved in ion binding. We have also been able to use our crystal structures as scaffolds to model the possible structural effects of missense mutations that have been identified in factor XIII-deficient patients.
已使用单晶X射线衍射方法确定了几种形式的因子XIII A亚基的三维结构。我们的晶体学研究首次提供了因子XIII A亚基的详细结构视图以及有助于理解转谷氨酰胺酶功能的信息。我们已在该分子的活性位点鉴定出一个由Cys314-His373-Asp396组成的保守催化三联体残基,以及一些可能也起重要作用的其他保守残基。钙和锶结构揭示了几个参与离子结合的保守酸性残基(Asp438、Glu485和Glu490)。我们还能够将我们的晶体结构用作支架,来模拟在因子XIII缺乏症患者中鉴定出的错义突变可能产生的结构效应。